{"protocolSection":{"identificationModule":{"nctId":"NCT02396069","orgStudyIdInfo":{"id":"JP-NC-P1-14"},"organization":{"fullName":"Jeil Pharmaceutical Co., Ltd.","class":"INDUSTRY"},"briefTitle":"The Evaluation of Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of JPI-289 in Healthy Male Volunteers","officialTitle":"A Phase I Clinical Study, Randomized, Double-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of JPI-289 in Healthy Male Volunteers."},"statusModule":{"statusVerifiedDate":"2015-03","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2015-03"},"primaryCompletionDateStruct":{"date":"2015-08","type":"ACTUAL"},"completionDateStruct":{"date":"2015-08","type":"ACTUAL"},"studyFirstSubmitDate":"2015-03-12","studyFirstSubmitQcDate":"2015-03-17","studyFirstPostDateStruct":{"date":"2015-03-24","type":"ESTIMATED"},"lastUpdateSubmitDate":"2016-06-23","lastUpdatePostDateStruct":{"date":"2016-06-24","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Jeil Pharmaceutical Co., Ltd.","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"Double blind, randomized, placebo control, multiple dose, dose escalation study","detailedDescription":"A phase I clinical study, randomized, double-blind, placebo-controlled, multiple doses, dose escalation study of the safety, tolerability and pharmacokinetics/pharmacodynamics of JPI-289 in healthy male volunteers."},"conditionsModule":{"conditions":["Stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE1"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"DOUBLE","whoMasked":["PARTICIPANT","INVESTIGATOR"]}},"enrollmentInfo":{"count":24,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"JPI-289","type":"EXPERIMENTAL","description":"Each cohort, volunteers will be infused JPI-289 for 60 min. (6 volunteers per each cohort, total 3 cohort)","interventionNames":["Drug: JPI-289"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","description":"Each cohort, volunteer will be infused placebo for 60 min. (2 volunteers per each cohort, total 3 cohort)","interventionNames":["Drug: Placebo"]}],"interventions":[{"type":"DRUG","name":"JPI-289","description":"PARP-1 inhibitor","armGroupLabels":["JPI-289"]},{"type":"DRUG","name":"Placebo","description":"Placebo","armGroupLabels":["Placebo"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"AUCτ,ss and Cmax,ss(76h), Relative PAR level(73h,%)","timeFrame":"96 hours, 73 hours"}],"secondaryOutcomes":[{"measure":"Cav,ss","timeFrame":"96 hours"},{"measure":"t1/2β","timeFrame":"96 hours"},{"measure":"Vd,ss","timeFrame":"96 hours"},{"measure":"CL","timeFrame":"96 hours"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* 19\\~55 years healthy male\n* BMI measurement 20kg/m²\\~27kg/m²\n* 90 ≤ SBP\\<140(mmHg) 60 ≤ DBP\\<100(mmHg) 45 ≤ Pulse rate\\<100(bpm)\n* Signed the informed consent form to participate voluntarily and to comply with the trial requirements\n* For a follow-up visit and during the study period, blood samples and availability\n\nExclusion Criteria:\n\n* History of clinically significant hepatic, gastrointestinal, pulmonary, musculoskeletal, endocrine, psychiatric, hematooncologic, cardiovascular (Specially asthma, obstructive pulmonary disease, peptic ulcer)\n* History of skin disease of graft affecting absorption of the drug\n* History of drug abuse\n* Positive urine drug screening\n* Administrated investigational product in a previous clinical trial within 60 days of the screening test\n* Donated blood within 60 days prior to screening test","healthyVolunteers":true,"sex":"MALE","minimumAge":"19 Years","maximumAge":"55 Years","stdAges":["ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Hyeong-Seok Lim, M.D.,Ph.D.","affiliation":"Asan Medical Center","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Asan Medical Center","city":"Seoul","state":"Songpa-Gu","zip":"138-736","country":"Korea, Republic of","geoPoint":{"lat":37.566,"lon":126.9784}}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"}]}},"hasResults":false}